OOIR: Observatory of International Research

Papers

(The H4-Index of EMBO Molecular Medicine is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders	260
Circulating proteomic panels for risk stratification of intracranial aneurysm and its rupture	180
THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer	142
Whole‐brain microscopy reveals distinct temporal and spatial efficacy of anti‐Aβ therapies	99
HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy	85
Targeting the Leukemic stem cell protein machinery by inhibition of mitochondrial pyrimidine synthesis	81
Targeting conformational changes in C‐reactive protein to inhibit pro‐inflammatory actions	80
TFEB and TFE3 drive kidney cystogenesis and tumorigenesis	76
A preclinical model of peripheral T‐cell lymphoma GATA3 reveals DNA damage response pathway vulnerability	76
Targetable Brg1‐CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking	65
Activation of the integrated stress response is a vulnerability for multidrug‐resistant FBXW7 ‐deficient cells	64
When fat meets the gut—focus on intestinal lipid handling in metabolic health and disease	62
Depressive patient‐derived GABA interneurons reveal abnormal neural activity associated with HTR2C	59
Elongator and the role of its subcomplexes in human diseases	57
IQCN disruption causes fertilization failure and male infertility due to manchette assembly defect	56
Metformin rescues migratory deficits of cells derived from patients with periventricular heterotopia	55
Diagnostic biomarkers for active tuberculosis: progress and challenges	55
ASO targeting RBM3 temperature‐controlled poison exon splicing prevents neurodegeneration in vivo	54
Identification of treatment‐induced vulnerabilities in pancreatic cancer patients using functional model systems	52
Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain	51
Eosinophil‐derived IL ‐4 is necessary to establish the inflammatory structure in innate inflammation	51
Systemic inflammation after stroke: implications for post‐stroke comorbidities	51
Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer	50
Active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model	49
Nerve regeneration by interferon intervention in aging brain	48

Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy	46
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination	44
Functions of double‐negative B cells in autoimmune diseases, infections, and cancers	43
Shear stress control of vascular leaks and atheromas through Tie2 activation by VE‐PTP sequestration	42
ALX1 ‐related frontonasal dysplasia results from defective neural crest cell development and migration	42
Mining the bacterial genome to discover new antimicrobial molecules	42
Single‐cell profiling of muscle‐infiltrating T cells in idiopathic inflammatory myopathies	42
Macrophage colony‐stimulating factor as a weapon against cytomegalovirus	42
Optimizing the Cas13 antiviral train: cargo and delivery	41
Looking at a baby's heart through the lens of the mother's blood	41
A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis	40
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV ‐2	40
A coordinated multiorgan metabolic response contributes to human mitochondrial myopathy	39
Advances in high‐throughput mass spectrometry in drug discovery	39
In vivo single‐cell transcriptomics reveal Klebsiella pneumoniae skews lung macrophages to promote infection	39
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma	39